So far, AM-Pharma received around € 55M in venture capital funding. The last funding round was a € 29.3M first close of a D-round in September 2011.
In addition in March 2009, the Dutch Ministry of Economic Affairs granted AM-Pharma a loan of up to € 5M.
Our main investors are:
Ysios Capital Partners
Kurma Life Science Partners
Forbion Capital Partners
Inventages Venture Capital
Abbott
Shire
BB Biotech Ventures
Idinvest